{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:02:34Z","timestamp":1790704954410,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009785","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000}}],"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI127984"],"award-info":[{"award-number":["AI127984"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI148763"],"award-info":[{"award-number":["AI148763"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Rift Valley fever virus (RVFV) is a mosquito-borne bunyavirus with a wide host range including ruminants and humans. RVFV outbreaks have had devastating effects on public health and the livestock industry in African countries. However, there is no approved RVFV vaccine for human use in non-endemic countries and no FDA-approved antiviral drug for RVFV treatment. The RVFV 78kDa protein (P78), which is a membrane glycoprotein, plays a role in virus dissemination in the mosquito host, but its biological role in mammalian hosts remains unknown. We generated an attenuated RVFV MP-12 strain-derived P78-High virus and a virulent ZH501 strain-derived ZH501-P78-High virus, both of which expressed a higher level of P78 and carried higher levels of P78 in the virion compared to their parental viruses. We also generated another MP-12-derived mutant virus (P78-KO virus) that does not express P78. MP-12 and P78-KO virus replicated to similar levels in fibroblast cell lines and Huh7 cells, while P78-High virus replicated better than MP-12 in Vero E6 cells, fibroblast cell lines, and Huh7 cells. Notably, P78-High virus and P78-KO virus replicated less efficiently and more efficiently, respectively, than MP-12 in macrophage cell lines. ZH501-P78-High virus also replicated poorly in macrophage cell lines. Our data further suggest that inefficient binding of P78-High virus to the cells led to inefficient virus internalization, low virus infectivity and reduced virus replication in a macrophage cell line. P78-High virus and P78-KO virus showed lower and higher virulence than MP-12, respectively, in young mice. ZH501-P78-High virus also exhibited lower virulence than ZH501 in mice. These data suggest that high levels of P78 expression attenuate RVFV virulence by preventing efficient virus replication in macrophages. Genetic alteration leading to increased P78 expression may serve as a novel strategy for the attenuation of RVFV virulence and generation of safe RVFV vaccines.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009785","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T13:32:26Z","timestamp":1631539946000},"page":"e0009785","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6997-8689","authenticated-orcid":true,"given":"Kaori","family":"Terasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"Kalveram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9824-1846","authenticated-orcid":true,"given":"Kendra N.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Juelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-8960","authenticated-orcid":true,"given":"Alexander N.","family":"Freiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-1576","authenticated-orcid":true,"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"pntd.0009785.ref001","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa","volume":"34","author":"R Daubney","year":"1931","journal-title":"J Pathol Bacteriol"},{"key":"pntd.0009785.ref002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2018.05.009","article-title":"Rift Valley fever in animals and humans: Current perspectives","volume":"156","author":"CM McMillen","year":"2018","journal-title":"Antiviral Res"},{"issue":"2","key":"pntd.0009785.ref003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cll.2017.01.004","article-title":"Rift Valley Fever.","volume":"37","author":"A. Hartman","year":"2017","journal-title":"Clin Lab Med"},{"issue":"11","key":"pntd.0009785.ref004","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1016\/S2214-109X(16)30176-0","article-title":"Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study","volume":"4","author":"M Baudin","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pntd.0009785.ref005","doi-asserted-by":"crossref","first-page":"e0007898","DOI":"10.1371\/journal.pntd.0007898","article-title":"Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas.","volume":"14","author":"J Oymans","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0009785.ref006","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jmedent\/47.5.884","article-title":"Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus.","volume":"47","author":"MJ Turell","year":"2010","journal-title":"J Med Entomol"},{"issue":"4","key":"pntd.0009785.ref007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/mve.12254","article-title":"Rift Valley fever virus and European mosquitoes: vector competence of Culex pipiens and Stegomyia albopicta (= Aedes albopictus).","volume":"31","author":"M Brustolin","year":"2017","journal-title":"Med Vet Entomol"},{"key":"pntd.0009785.ref008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"MS Mehand","year":"2018","journal-title":"Antiviral Res"},{"issue":"24","key":"pntd.0009785.ref009","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein","volume":"86","author":"SM de Boer","year":"2012","journal-title":"J Virol"},{"issue":"36","key":"pntd.0009785.ref010","doi-asserted-by":"crossref","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Y Wu","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pntd.0009785.ref011","article-title":"Electron Cryo-Microscopy and Single-Particle Averaging of Rift Valley Fever Virus: Evidence for GN-GC Glycoprotein Heterodimers","author":"JT Huiskonen","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"pntd.0009785.ref012","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02789-2","article-title":"Shielding and activation of a viral membrane fusion protein","volume":"9","author":"S Halldorsson","year":"2018","journal-title":"Nature Communications"},{"issue":"11","key":"pntd.0009785.ref013","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"SM de Boer","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0009785.ref014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"RB Mandell","year":"2010","journal-title":"Virology"},{"issue":"16","key":"pntd.0009785.ref015","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1128\/JVI.00476-06","article-title":"NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture","volume":"80","author":"S Won","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"pntd.0009785.ref016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0042-6822(89)90442-X","article-title":"Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation","volume":"170","author":"LT Kakach","year":"1989","journal-title":"Virology"},{"issue":"1","key":"pntd.0009785.ref017","doi-asserted-by":"crossref","first-page":"e87385","DOI":"10.1371\/journal.pone.0087385","article-title":"Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6\/36 cells.","volume":"9","author":"HM Weingartl","year":"2014","journal-title":"PLoS One."},{"issue":"e71","key":"pntd.0009785.ref018","article-title":"The Rift Valley fever accessory proteins NSm and P78\/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts","volume":"3","author":"F. Kreher","year":"2014","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"pntd.0009785.ref019","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.","volume":"73","author":"UJ Buchholz","year":"1999","journal-title":"J Virol"},{"issue":"Pt 10","key":"pntd.0009785.ref020","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"H Caplen","year":"1985","journal-title":"J Gen Virol"},{"issue":"6","key":"pntd.0009785.ref021","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"T Ikegami","year":"2006","journal-title":"J Virol"},{"issue":"4","key":"pntd.0009785.ref022","doi-asserted-by":"crossref","first-page":"e9986","DOI":"10.1371\/journal.pone.0009986","article-title":"Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA","volume":"5","author":"JC Morrill","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"pntd.0009785.ref023","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/jvi.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"K Keegan","year":"1986","journal-title":"J Virol"},{"key":"pntd.0009785.ref024","doi-asserted-by":"crossref","first-page":"113701","DOI":"10.1016\/j.jviromet.2019.113701","article-title":"A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus","volume":"272","author":"B Tercero","year":"2019","journal-title":"J Virol Methods"},{"issue":"2","key":"pntd.0009785.ref025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","article-title":"Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes","volume":"44","author":"M. Kozak","year":"1986","journal-title":"Cell"},{"key":"pntd.0009785.ref026","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jim.2016.01.012","article-title":"The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus","volume":"430","author":"ME Lund","year":"2016","journal-title":"J Immunol Methods"},{"issue":"7","key":"pntd.0009785.ref027","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1128\/jvi.69.7.3972-3979.1995","article-title":"The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules","volume":"69","author":"N Lopez","year":"1995","journal-title":"J Virol"},{"issue":"Pt 4","key":"pntd.0009785.ref028","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1099\/0022-1317-82-4-781","article-title":"Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates","volume":"82","author":"L Accardi","year":"2001","journal-title":"J Gen Virol"},{"issue":"9","key":"pntd.0009785.ref029","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1128\/JVI.79.9.5606-5615.2005","article-title":"Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system","volume":"79","author":"T Ikegami","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"pntd.0009785.ref030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"PY Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"29","key":"pntd.0009785.ref031","doi-asserted-by":"crossref","first-page":"20440","DOI":"10.1074\/jbc.M601925200","article-title":"Widely Divergent Biochemical Properties of the Complete Set of Mouse DC-SIGN-related Proteins","volume":"281","author":"AS Powlesland","year":"2006","journal-title":"J Biol Chem"},{"issue":"5","key":"pntd.0009785.ref032","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.0510251","article-title":"Expression of C-type lectin, SIGNR3, on subsets of dendritic cells, macrophages, and monocytes","volume":"88","author":"K Nagaoka","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"21","key":"pntd.0009785.ref033","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1128\/JVI.01191-08","article-title":"Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography","volume":"82","author":"AN Freiberg","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"pntd.0009785.ref034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2009.02.038","article-title":"Single-particle cryo-electron microscopy of Rift Valley fever virus","volume":"387","author":"MB Sherman","year":"2009","journal-title":"Virology"},{"issue":"6363","key":"pntd.0009785.ref035","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aal2712","article-title":"A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion","volume":"358","author":"P Guardado-Calvo","year":"2017","journal-title":"Science"},{"issue":"7","key":"pntd.0009785.ref036","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v11070596","article-title":"Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?","volume":"11","author":"Tseligka Cagno","year":"2019","journal-title":"Viruses"},{"issue":"11","key":"pntd.0009785.ref037","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/infdis\/jiy081","article-title":"The Role of Heparan Sulfate Proteoglycans as an Attachment Factor for Rabies Virus Entry and Infection","volume":"217","author":"M Sasaki","year":"2018","journal-title":"J Infect Dis"},{"issue":"6","key":"pntd.0009785.ref038","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/cells9061486","article-title":"Hepatitis B Virus Entry into Cells.","volume":"9","author":"C Herrscher","year":"2020","journal-title":"Cells"},{"issue":"5","key":"pntd.0009785.ref039","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","article-title":"Herpes simplex virus: receptors and ligands for cell entry","volume":"6","author":"PG Spear","year":"2004","journal-title":"Cellular Microbiology"},{"issue":"6","key":"pntd.0009785.ref040","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.celrep.2018.04.013","article-title":"TIM-1 Ubiquitination Mediates Dengue Virus Entry","volume":"23","author":"O Dejarnac","year":"2018","journal-title":"Cell Reports"},{"issue":"1","key":"pntd.0009785.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0137-7","article-title":"Bona fide receptor for hepatitis B and D viral infections: Mechanism, research models and molecular drug targets.","volume":"7","author":"Y Yu","year":"2018","journal-title":"Emerging Microbes & Infections."},{"issue":"24","key":"pntd.0009785.ref042","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan sulfate facilitates Rift Valley fever virus entry into the cell","volume":"86","author":"SM de Boer","year":"2012","journal-title":"J Virol"},{"issue":"10","key":"pntd.0009785.ref043","doi-asserted-by":"crossref","first-page":"e0005047","DOI":"10.1371\/journal.pntd.0005047","article-title":"Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.","volume":"10","author":"K Terasaki","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"issue":"12","key":"pntd.0009785.ref044","doi-asserted-by":"crossref","first-page":"e1421","DOI":"10.1371\/journal.pntd.0001421","article-title":"Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.","volume":"5","author":"C Gommet","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0009785.ref045","doi-asserted-by":"crossref","first-page":"27719","DOI":"10.1038\/srep27719","article-title":"A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.","volume":"6","author":"B Faburay","year":"2016","journal-title":"Scientific Reports"},{"issue":"1","key":"pntd.0009785.ref046","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0300985818806049","article-title":"Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Adult Sheep","volume":"56","author":"L Odendaal","year":"2019","journal-title":"Vet Pathol"},{"issue":"1","key":"pntd.0009785.ref047","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","article-title":"Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection","volume":"422","author":"AK McElroy","year":"2012","journal-title":"Virology"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009785","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T11:09:18Z","timestamp":1632481758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009785"}},"subtitle":[],"editor":[{"given":"Jonas","family":"Klingstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009785","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}